BPTH – bio-path holdings, inc. (US:NASDAQ)
Stock Stats
News
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients [Yahoo! Finance]
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients
Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 19
Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 12
Form 8-K BIO-PATH HOLDINGS, INC. For: Dec 11
Form 8-K BIO-PATH HOLDINGS, INC. For: Nov 19
Form 8-K BIO-PATH HOLDINGS, INC. For: Nov 15
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.